glp-1/fgf21 agonist boehringer Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs Weight-loss maintenance is accompanied by

PEER REVIEW The peer review history for this article is available at Supporting information ACKNOWLEDGEMENTS This research was performed as a part of the institutional activity of the unit, with no specific funding

Helpful strategies: Start the day with protein-rich meals Avoid late-night eating Maintain consistent meal timing Some patients benefit from time-restricted eating, which may enhance GLP-1 release

GLP-1 also influences the pancreas, liver, brain, and cardiovascular system, which explains its wide-reaching benefits beyond just controlling appetite

some cover GLP-1s for diabetes indications more readily than for obesity

To your health

Additionally, exendin (a GLP-1R agonist) assays (central and peripheral administration), mRNA central nervous system (CNS) analysis, immunohistochemistry, and fluorescently labeled liraglutide assays were conducted